IL6 and acute myeloid leukemia: Our study reveals that the interplay between osteoblasts and AML cells through the mTORC1/IL-6-IL-6R/JAK/STAT3 axis contributes to the feedforward loop of AML progression, suggesting that modifying this axis could offer an effective strategy for disease management and relapse prevention.